References
- Galazka AM, Robertson SE, Kraigher A. Mumps and mumps vaccine: A global review. Bull World Health Organ 1999;77:3-14
- Cohen C, White JM, Savage EJ, Glynn JR, Choi Y, Andrews N et al. Vaccine effectiveness estimates, 2004-2005 mumps outbreak, England. Emerg Infect Dis 2007;13:12-17
- Gupta RK, Best J, MacMahon E. Mumps and the UK epidemic 2005. BMJ 2005;330:1132-1135 https://doi.org/10.1136/bmj.330.7500.1132
- Bloom S, Wharton M. Mumps outbreak among young adults in UK. BMJ 2005;331:E363-364 https://doi.org/10.1136/bmj.331.7513.363
- CDC. Update: Multistate outbreak of mumps--United States, January 1-May 2, 2006. MMWR 2006;55:559-563
- Vandermeulen C, Roelants M, Vermoere M, Roseeuw K, Goubau P, Hoppenbrouwers K. Outbreak of mumps in a vaccinated child population: A question of vaccine failure. Vaccine 2004;22:2713-2716 https://doi.org/10.1016/j.vaccine.2004.02.001
- Marin M, Quinlisk P, Shimabukuro T, Sawhney C, Brown C, LeBaron CW. Mumps vaccination coverage and vaccine effectiveness in a large outbreak among college students--Iowa, 2006. Vaccine 2008;26:3601-3607 https://doi.org/10.1016/j.vaccine.2008.04.075
- Park BC, Cheong HK, Lim HS, Kim DS, Kim D. Epidemiologic investigation of a mumps outbreak in a middle school in Pohang, Korea. Korean Journal Epidemiology 2000;22:148-158 (Korean)
- KCDC. Epidemiology and prevention of vaccinepreventable disease. 2006(Korean)
- WHO. Mumps virus vaccines-WHO position paper. Weekly Epidemiological Record 2001;76: 345-356
- Division of VPD control and NIP. KCDC. Vaccine coverage. Monthly Newsletter for National Immunization Program 2007;5:6-27 (Korean)
- Ki M, Kim CH, Choi B, Kang C, Lee DH, Park O et al. Evaluation of mumps outbreak and serology. KCDC, 2008. (Korean)
- WHO. WHO-recommended standards for surveillance of selected vaccine-preventable diseases, 2003
- Sanz JC, Del Mar Mosquera M, Echevarria JE, Fernandez M, Herranz N, Palacios G et al. Sensitivity and specificity of immunoglobulin G titer for the diagnosis of mumps virus in infected patients depending on vaccination status. APMIS 2006;114:788-794 https://doi.org/10.1111/j.1600-0463.2006.apm_463.x
- Krause CH, Molyneaux PJ, Ho-Yen DO, McIntyre P, Carman WF, Templeton KE. Comparison of mumps-IgM ELISA in acute infection. Journal of Clinical Virology 2007;38:153-156 https://doi.org/10.1016/j.jcv.2006.10.010
- Dade Behring. Enzygnost anti-parotitis-virus/ IgG (product manual). In, 2003; 2-10
- CDC. VPD surveillance manual. In: Zimmerman L, Reef S, Wharton M, eds. Mumps. third ed. Atlanta, 2002
- Orenstein WA, Bernier RH, Dondero TJ, Hinman AR, Marks JS, Bart KJ et al. Field evaluation of vaccine efficacy. Bull World Health Organ 1985; 63:1055-1068
- Kim-Farley R, Bart S, Stetler H, Orenstein W, Bart K, Sullivan K et al. Clinical mumps vaccine efficacy. Am. J. Epidemiol. 1985;121:593-597 https://doi.org/10.1093/oxfordjournals.aje.a114037
- Schaffzin JK, Pollock L, Schulte C, Henry K, Dayan G, Blog D et al. Effectiveness of previous mumps vaccination during a summer camp outbreak. Pediatrics 2007;120:e862-868 https://doi.org/10.1542/peds.2006-3451
- Harling R, White JM, Ramsay ME, Macsween KF, Bosch Cvd. The effectiveness of the mumps component of the MMR vaccine: A case control study. Vaccine 2005;23:4070-4074 https://doi.org/10.1016/j.vaccine.2004.10.020
- Fu C, Liang J, Wang M. Effectiveness of live attenuated s79 mumps vaccine against clinical mumps: A matched case-control study. Clin. Vaccine Immunol. 2008:CVI.00122-00108
- Division of Epidemic Intelligence Service. KCDC, Division of Influenza and Respiratory Viruses, KNIH. Seroepidemiology of measles and mumps among preschool children. Public Health Weekly Report 2008;1:49-53